Meta-Analysis on the Effect of Off-Pump Coronary Bypass Surgery
Objective: To assess the effect of conventional coronary artery bypass surgery (CABG) compared to the off-pump procedure (OPCAB). Methods: Based on randomised […]
Transfusion Protocols for Pediatric Cardiac Patients
OBJECTIVES: Low-hematocrit bypass is one technique used to prevent allogeneic transfusion during cardiopulmonary bypass. The purpose of this study is to determine […]
Platelet-Derived Growth Factors Enhance Proliferation of Human Stromal Stem Cells
Studies on new procedures for bone reconstruction suggest that autologous cells seeded on a resorbable scaffold can improve the treatment of bone […]
High-grade Stenosis of Proximal LAD Responds Better to CABG Than Stenting
In patients with high-grade stenosis in the proximal left anterior descending coronary artery (LAD), outcomes after coronary artery bypass grafting (CABG) are […]
Extreme Hemodilution During CABG Linked to Kidney Damage
NEW YORK (Reuters Health) – Nadir hematocrit caused by hemodilution during coronary artery bypass graft (CABG) surgery appears to be associated with […]
Nonsurgical Septal Reduction Advantageous in Hypertrophic Cardiomyopathy
Nonsurgical septal reduction brings hemodynamic and morphological improvements superior to those of dual-chamber pacing in patients with hypertrophic obstructive cardiomyopathy, according to […]
Primary Stenting More Costly Over the Long Term than CABG or PTCA
NEW YORK (Reuters Health) – The estimated long-term costs of primary stenting in patients with multivessel coronary disease appear to be higher […]
Silent’ Strokes Common and Linked to Dementia
NEW YORK (Reuters Health) – People who experience so-called silent strokes face more than twice the risk of developing dementia as those […]
Washington Hospital Center Performs First TMR Surgery With PLC Systems’ Next-Generation CO2 Heart Laser 2(TM)
PLC Systems Inc. (Amex: PLC), the leader in carbon dioxide (CO2) transmyocardial revascularization (TMR), announced that on March 12, 2001, Dr. Stephen […]
VEGF Gene Therapy for Heart Failure Reaching Phase III Trials
Gene therapy, using Vascular Endothelial Growth Factor 121 (AdVEGF121, Biobypass, GenVec, Gaithersburg, MD), effectively induces regrowth of blood vessels and improves exercise […]
Abiomed Says FDA OKs AbioCor Heart Patient Group
CHICAGO (Reuters) – Medical device maker Abiomed Inc. said on Monday that U.S. regulators have taken preliminary steps toward approval of its […]
Two Stem Cell Studies Show Heart Tissue Regeneration Following Infarcts
Evidence that bone-marrow stem-cell transplantation could regenerate damaged cells in the heart after myocardial infarction is demonstrated by separate research among teams […]